Admission Date:  [**2127-5-28**]              Discharge Date:   [**2127-5-31**]  Date of Birth:  [**2080-2-23**]             Sex:   F  Service: MEDICINE  Allergies: Morphine / Demerol / Dilaudid  Attending:[**First Name3 (LF) 45556**] Chief Complaint: Hypotension  Major Surgical or Invasive Procedure: None.
Received 1 L NS in clinic.
She was given an additional 4 L NS and remained hypotensive to the 90s systolic, and T was 101 rectally.
She was started on code sepsis and a central line (RIJ) was placed.
She was given 1 gram of vancomycin IV, 1 g of ceftazadime IV, dexamethasone 4 mg IV, and one amp of D50 for glucose of 36-->135.
Also given 1 amp calcium gluconate for a calcium of 6.6. .
+decreased appetite and poor po intake past 2-3 weeks.
Hypothyroidism s/p thyroidectomy  Oncologic history: In [**2114**], pt was diagnosed with right breast ductal carcinoma in situ.
She is s/p a right mastectomy and right axillary lymphadenectomy ([**Hospital **] Hospital).
She had adriamycin/cytoxan, taxol, and then radiation treatment and was on arimidex post-trt.
She was eventually dxd with thyroid ca and is s/p thyroidectomy and radioactive iodine.
She had local wide excision and sentinel lymph node biopsy (negative).
[**2127-5-28**] 08:00PM URINE  COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.003 [**2127-5-28**] 08:00PM URINE  RBC-0-2 WBC-0-2 BACTERIA-FEW YEAST-NONE EPI-0-2 [**2127-5-28**] 07:40PM   CORTISOL-13.4 [**2127-5-28**] 07:28PM   TYPE-[**Last Name (un) **] PO2-65* PCO2-41 PH-7.38 TOTAL CO2-25 BASE XS-0 COMMENTS-GREEN TOP [**2127-5-28**] 07:28PM   LACTATE-2.6* [**2127-5-28**] 07:28PM   HGB-7.9* calcHCT-24 O2 SAT-92 [**2127-5-28**] 06:23PM   TYPE-[**Last Name (un) **] COMMENTS-NOT SPECIF [**2127-5-28**] 06:23PM   LACTATE-3.9* [**2127-5-28**] 06:00PM   GLUCOSE-37* UREA N-15 CREAT-1.1 SODIUM-138 POTASSIUM-4.0 CHLORIDE-104 TOTAL CO2-20* ANION GAP-18 [**2127-5-28**] 06:00PM   CALCIUM-6.4* PHOSPHATE-2.8 MAGNESIUM-1.6 [**2127-5-28**] 06:00PM   WBC-66.5* RBC-2.39* HGB-7.4* HCT-22.5* MCV-95 MCH-30.9 MCHC-32.7 RDW-14.6 [**2127-5-28**] 06:00PM   NEUTS-88* BANDS-8* LYMPHS-1* MONOS-2 EOS-0 BASOS-0 ATYPS-0 METAS-1* MYELOS-0 [**2127-5-28**] 02:00PM   PLT SMR-NORMAL PLT COUNT-264 [**2127-5-28**] 02:00PM   HYPOCHROM-OCCASIONAL ANISOCYT-1+ POIKILOCY-OCCASIONAL MACROCYT-OCCASIONAL MICROCYT-1+ POLYCHROM-OCCASIONAL OVALOCYT-OCCASIONAL [**2127-5-28**] 02:00PM   NEUTS-93* BANDS-1 LYMPHS-2* MONOS-1* EOS-1 BASOS-0 ATYPS-0 METAS-1* MYELOS-0 PROMYELO-1* [**2127-5-28**] 02:00PM   WBC-90.2* RBC-3.03* HGB-8.9* HCT-27.0* MCV-89 MCH-29.4 MCHC-33.1 RDW-14.9 [**2127-5-28**] 02:00PM   LD(LDH)-443* [**2127-5-28**] 06:00PM   PLT COUNT-218  Brief Hospital Course: Ms. [**Known lastname **] is a 47 yo female with breast cancer, thyroid cancer, and metastatic melanoma who presents to the ED hypotensive and febrile.
In the ED she was given an additional 4L with minimal response in BP and was found to be febrile to 101 rectally.
A central line was placed and she was started on a code sepsis.
She was started empirically on Cefepime and Vancomycin and given an additional 3L of NS.
While on the floor, antibiotics were changed to PO dicloxicillin to treat skin flora.
She was extrememely uncomfortable and was given a bowel regimen and eventually a Fleet enema when the bowel regimen did not work.
She was started on hydrocortisone, 50 mg q6 hours and fludrocortisone, 0.5 mg daily.
The patient will be discharged with Hydrocortisone 30mg po q 8hours without Fludricortisone.
The patient has been instructed to continue replacement at the current dose with taper to VNA by the patient's primary oncologist.
Pain control: She was maintained on fentanyl patch for comfort/pain despite the fact that it can lead to lower BPs, as well as methadone per outpatient doses.
She was hesitant to try morphine during the hospitalization as this medication has led to nausea/vomiting in past.
She was restarted on outpatient tramadol with good response.
She may require an increased dose of fentanyl patch (from 25 to 50) or adding fentanyl PRNs (or other med for breakthrough pain) as disease progresses.
Breast cancer: Ms. [**Known lastname **] was taking aramedix as an outpatient.
She was continued on levoxyl per her outpatient dose.
Medications on Admission: Arimidex Levoxyl 137 mcg qday Fentanyl patch 25 mcg Methadone 2.5-5 mg q6 hr prn Tramadol 50-100 mg prn Ativan 0.5-1 mg prn   Discharge Medications: 1.
Levothyroxine 137 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Methadone 5 mg Tablet Sig: 0.5-1 Tablet PO QID (4 times a day) as needed for pain.
Fentanyl 25 mcg/hr Patch 72HR Sig: One (1) Patch 72HR Transdermal Q72H (every 72 hours).
Disp:*10 Patch 72HR(s)* Refills:*2* 4.
Hydrocortisone 20 mg Tablet Sig: 1.5 Tablets PO Q8H (every 8 hours): Please take as prescribed until instructed to decrease dose.
Tramadol 50 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Dicloxacillin 250 mg Capsule Sig: One (1) Capsule PO Q6H (every 6 hours) for 10 days.
Lorazepam 1 mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO DAILY (Daily): Hold for diarrhea.
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
)(s)* Refills:*2*   Discharge Disposition: Home With Service  Facility: [**Last Name (LF) 486**], [**First Name3 (LF) 487**]  Discharge Diagnosis: Primary: Metastatic melanoma Secondary: Breast cancer Thyroid cancer Hypothyroidism s/p thyroidectomy   Discharge Condition: Stable, patient going home with VNA bridge to hospice as previously planned   Discharge Instructions: Please take all medications as instructed.
Please make any outpatient appointments with your providers as needed or desired.
